Patents by Inventor Graham Ernest Robinson

Graham Ernest Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4115580
    Abstract: The disclosure relates to .omega.-aryl substituted .omega.-nor prostaglandin analogues bearing an oxygenated function at C-10, such as a hydroxy radical, or a 9,10- or 10,11-epoxide. A typical compound is 16-(3-chlorophenoxy)-9.alpha.,10.beta.,11.alpha.,15.alpha.-tetrahydroxy-17 ,18,19,20-tetranor-5-cis,13-trans-prostadienoic acid. Also disclosed are chemical processes for the manufacture of said compounds, pharmaceutical and veterinary compositions containing said compounds, and a method of achieving luteolysis in mammals by the use of such compounds.
    Type: Grant
    Filed: July 18, 1977
    Date of Patent: September 19, 1978
    Assignee: Imperial Chemical Industries Limited
    Inventors: Jean Bowler, Graham Ernest Robinson
  • Patent number: 4092323
    Abstract: The disclosure relates to novel protected ketone derivatives, for example dimethyl 3-(3-chlorophenoxy)-2-semicarbazonopropylphosphonate, for use as intermediates in the synthesis of known prostaglandin analogues, and to a process for their manufacture.
    Type: Grant
    Filed: May 9, 1977
    Date of Patent: May 30, 1978
    Assignee: Imperial Chemical Industries Limited
    Inventors: Robert Foster, Roger Edwin Preston, Graham Ernest Robinson
  • Patent number: 4079055
    Abstract: The disclosure relates to a novel chemical process whereby enone intermediates for prostaglandins are reduced steroselectively to the .alpha.-enols, the .alpha.-hydroxy of which corresponds to the prostaglandin 15.alpha.-hydroxy group.
    Type: Grant
    Filed: May 21, 1976
    Date of Patent: March 14, 1978
    Assignee: Imperial Chemical Industries Limited
    Inventors: Keith Blakeney Mallion, Graham Ernest Robinson
  • Patent number: 4046841
    Abstract: The disclosure relates to novel protected ketone derivatives, for example dimethyl 3-(3-chlorophenoxy)-2-semicarbazonopropylphosphonate, for use as intermediates in the synthesis of known prostaglandin analogues, and to a process for their manufacture.
    Type: Grant
    Filed: August 30, 1976
    Date of Patent: September 6, 1977
    Assignee: Imperial Chemical Industries Limited
    Inventors: Robert Foster, Roger Edwin Preston, Graham Ernest Robinson